Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eoin R Feeney

Showing results (1-10 of 34) with videos related to

Pageof 4
Sort By:
BMJ (Clinical Research Ed.)|July 9, 2014
Antiviral treatment of hepatitis CEoin R Feeney, Raymond T Chung
Current Pharmaceutical Design|August 7, 2010
Impact of mitochondrial toxicity of HIV-1 antiretroviral drugs on lipodystrophy and metabolic dysregulationEoin R Feeney, Patrick W G Mallon
The Open Cardiovascular Medicine Journal|June 7, 2011
HIV and HAART-Associated DyslipidemiaEoin R Feeney, Patrick W G Mallon
Current Opinion in HIV and AIDS|August 7, 2015
Current guidelines and prioritizing treatment of hepatitis C virus in HIV-infected patientsEoin R Feeney, Raymond T Chung, Yazdan Yazdanpanah
Nature Reviews. Gastroenterology & Hepatology|February 19, 2014
HCV and HIV co-infection: mechanisms and managementJennifer Y Chen, Eoin R Feeney, Raymond T Chung
Open Forum Infectious Diseases|December 18, 2015
Prolonged Use of Oritavancin for Vancomycin-Resistant Enterococcus faecium Prosthetic Valve EndocarditisJennifer A Johnson, Eoin R Feeney, David W Kubiak, et al.
Vaccines|October 26, 2024
Navigating the Landscape of B Cell Mediated Immunity and Antibody Monitoring in SARS-CoV-2 Vaccine Efficacy: Tools, Strategies and Clinical Trial InsightsSophie O'Reilly, Joanne Byrne, Eoin R Feeney, et al.
Clinical Medicine (London, England)|April 3, 2017
Getting to the heart of hypopituitarismJulie Martin-Grace, Mohamed Ahmed, Niall Mulvihill, et al.
AIDS (London, England)|February 19, 2011
High-density lipoprotein levels and 10-year cardiovascular risk in HIV-1-infected patientsAoife G Cotter, Claudette S Satchell, Jane A O'halloran, et al.
Scientific Reports|December 22, 2016
Chronic hepatitis C infection-induced liver fibrogenesis is associated with M2 macrophage activationMoses T Bility, Kouki Nio, Feng Li, et al.
Pageof 4

Showing results (1-10 of 34) with videos related to

Sort By:
Pageof 4
BMJ (Clinical Research Ed.)|July 9, 2014
Antiviral treatment of hepatitis CEoin R Feeney, Raymond T Chung
Current Pharmaceutical Design|August 7, 2010
Impact of mitochondrial toxicity of HIV-1 antiretroviral drugs on lipodystrophy and metabolic dysregulationEoin R Feeney, Patrick W G Mallon
The Open Cardiovascular Medicine Journal|June 7, 2011
HIV and HAART-Associated DyslipidemiaEoin R Feeney, Patrick W G Mallon
Current Opinion in HIV and AIDS|August 7, 2015
Current guidelines and prioritizing treatment of hepatitis C virus in HIV-infected patientsEoin R Feeney, Raymond T Chung, Yazdan Yazdanpanah
Nature Reviews. Gastroenterology & Hepatology|February 19, 2014
HCV and HIV co-infection: mechanisms and managementJennifer Y Chen, Eoin R Feeney, Raymond T Chung
Open Forum Infectious Diseases|December 18, 2015
Prolonged Use of Oritavancin for Vancomycin-Resistant Enterococcus faecium Prosthetic Valve EndocarditisJennifer A Johnson, Eoin R Feeney, David W Kubiak, et al.
Vaccines|October 26, 2024
Navigating the Landscape of B Cell Mediated Immunity and Antibody Monitoring in SARS-CoV-2 Vaccine Efficacy: Tools, Strategies and Clinical Trial InsightsSophie O'Reilly, Joanne Byrne, Eoin R Feeney, et al.
Clinical Medicine (London, England)|April 3, 2017
Getting to the heart of hypopituitarismJulie Martin-Grace, Mohamed Ahmed, Niall Mulvihill, et al.
AIDS (London, England)|February 19, 2011
High-density lipoprotein levels and 10-year cardiovascular risk in HIV-1-infected patientsAoife G Cotter, Claudette S Satchell, Jane A O'halloran, et al.
Scientific Reports|December 22, 2016
Chronic hepatitis C infection-induced liver fibrogenesis is associated with M2 macrophage activationMoses T Bility, Kouki Nio, Feng Li, et al.
Pageof 4